Medical Food Firm Stands Its Ground After FDA Repeats Recall Request
This article was originally published in The Rose Sheet
Executive Summary
Primus Pharmaceuticals say an insert in packages of its Limbrel capsules prescribed to manage metabolic processes associated with osteoarthritis advises that the ingredient baicalin could cause the lung condition acute hypersensitive pneumonitis and elevated liver enzymes in users with allergies to the flavonoid.
You may also be interested in...
Primus Has Experts' Support But Agrees With FDA To Recall Medical Food
Primus Pharmaceuticals voluntarily recalls unexpired lots of its Limbrel medical food available in 250 and 500 mg capsules. Other recent nutritional product sector recalls include Bulletproof 360's protein dietary supplement after a labeling error omitted milk as an ingredient.
Medical Food Firm's Production Investigated After Rash Of Adverse Events
FDA receives 194 adverse event reports regarding Primus Pharmaceuticals''s Limbrel medical food capsules, including two about "potentially life-threatening medical conditions." The agency says a likely relation was found between the product and the conditions reported in 30 of the AERs.
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.